fbpx Announcing the Advancing Joint Replacement Surgery QuickFire Challenge - News | JLABS

Announcing the Advancing Joint Replacement Surgery QuickFire Challenge

April 27, 2021 -
16 days ago
Other news

April 27, 2021 – While great strides have been made in robotic surgery, we can continue to reduce cost, increase efficiency, improve usability and simplify procedures for patients undergoing orthopaedic joint replacement surgery. 

Johnson & Johnson Innovation, together with the R&D organization of DePuy Synthes, announces the Advancing Joint Replacement Surgery QuickFire Challenge. Innovators are invited to submit concepts, prototypes and developed technologies that could potentially address current technology limitations in orthopaedic joint replacement surgery, such as:

  • Cost: High cost of capital equipment and per procedure disposable cost
  • Usability: Poor user experience including loss of tactile feedback, time inefficiency, and constraints on OR layout
  • Complexity: Injury and pain associated with pin sites used for bone markers, requirement to maintain line of sight with optical tracking arrays, inefficient and inaccurate bone registration

The innovator(s) with the best idea, technology, or potential solution aimed at advancing surgical solutions for orthopaedic joint replacement surgery will receive grant funding up to a total of $50,000, access to the global Johnson & Johnson Innovation - JLABS network and mentorship from experts at the Johnson & Johnson Family of Companies.

Apply at jji.jnj/joint-replacement by June 18, 2021.

The QuickFire Challenges are managed by Johnson & Johnson Innovation, with the goal to address today’s greatest health care challenges.

About Johnson & Johnson Innovation 

Johnson & Johnson Innovation LLC focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers; Johnson & Johnson Innovation JLABS; JJDC, Inc.; and our business development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. JLABS provides the laboratories, expertise, education, tools and resources needed to help life science startups thrive, all with no strings attached. A Johnson & Johnson Innovation Center for Device Innovation at the Texas Medical Center (CDI @ TMC) has been established to accelerate the development of medical devices. For more information about Johnson & Johnson Innovation, please visit: www.jnjinnovation.com.

About Johnson & Johnson Innovation - JLABS

Johnson & Johnson Innovation – JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators across a broad healthcare spectrum including pharmaceutical, medical device, consumer and health tech sectors to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS, we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS also produces campaigns to seek out the best science called QuickFire Challenges. For more information, visit www.jlabs.jnjinnovation.com or follow @JLABS. 

DePuy Synthes

DePuy Synthes, the Orthopaedics Company of Johnson & Johnson, provides one of the most comprehensive orthopaedics portfolios in the world that helps heal and restore movement for the millions of patients we serve. DePuy Synthes solutions, in specialties including joint reconstruction, trauma, craniomaxillofacial, spinal surgery and sport medicine, in addition to the VELYSTM Digital Surgery portfolio, are designed to advance patient care while delivering clinical and economic value to health care systems worldwide.

 

Building our proud product innovation and legacy of industry firsts, we are reimagining the orthopaedic landscape with new advancements in medical technologies and digital surgery across the entire continuum of care to Keep People Moving today and tomorrow.


Related content